Login / Signup

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities.

Ian N GlaspoleFrancesco BonellaElena BargagliMarilyn K GlassbergFabian CaroWibke StansenManuel QuaresmaLeticia OrsattiElisabeth Bendstrup
Published in: Respiratory research (2021)
ClinicalTrials.gov NCT00514683, NCT01335464, NCT01335477, NCT02788474, NCT01979952.
Keyphrases
  • idiopathic pulmonary fibrosis
  • interstitial lung disease
  • systemic sclerosis
  • rheumatoid arthritis